GlassScriptPhysician profile
Garth J Willis
NPI 1164639175
$3,146.99
in general payments reported to CMS, 2019-2025
23 companies · $365 in 2025
The $365 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $207 · 2021: $433 · 2022: $505 · 2023: $546 · 2024: $685 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $918.89 | 2019-2025 | Clareon, Rocklatan, Rhopressa |
| Abbvie INC. | $650.07 | 2022-2025 | Durysta, Lumigan, Vuity |
| Allergan, INC. | $433.17 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $146.86 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $135.42 | 2019-2022 | |
| Oyster Point Pharma, INC. | $98.60 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $97.89 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $88.62 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $84.09 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Rxsight INC | $81.99 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Shire North American Group INC | $71.43 | 2019 | |
| Ocular Therapeutix, INC. | $60.00 | 2022-2024 | Dextenza |
| Bausch & Lomb Americas INC. | $50.34 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Horizon Therapeutics Plc | $45.73 | 2022-2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31.79 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $28.54 | 2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $23.87 | 2019 | |
| Biotissue Holdings INC. | $20.56 | 2025 | |
| Glaukos Corporation | $18.39 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Omeros Corporation | $18.13 | 2021 | |
| Aerie Pharmaceuticals, INC. | $14.95 | 2019 | |
| Eyevance Pharmaceuticals LLC | $14.39 | 2020 | |
| Tearlab Corp | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garth Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.